Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034188
Filing Date
2025-03-06
Accepted
2025-03-06 08:10:51
Documents
104
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ikna-20241231.htm   iXBRL 10-K 3255678
2 EX-10.17 ikna-ex10_17.htm EX-10.17 86229
3 EX-10.18 ikna-ex10_18.htm EX-10.18 71521
4 EX-10.19 ikna-ex10_19.htm EX-10.19 13760
5 EX-23.1 ikna-ex23_1.htm EX-23.1 7238
6 EX-31.1 ikna-ex31_1.htm EX-31.1 13973
7 EX-31.2 ikna-ex31_2.htm EX-31.2 15035
8 EX-32.1 ikna-ex32_1.htm EX-32.1 15793
9 GRAPHIC img42595767_0.jpg GRAPHIC 135660
10 GRAPHIC img42595767_1.jpg GRAPHIC 129016
11 GRAPHIC img42595767_2.jpg GRAPHIC 296625
12 GRAPHIC img42595767_3.jpg GRAPHIC 156416
  Complete submission text file 0000950170-25-034188.txt   13280848

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ikna-20241231.xsd EX-101.SCH 1619542
107 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20241231_htm.xml XML 1595023
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40287 | Film No.: 25713676
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)